Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-16 5:24 pm Purchase |
2024-01-11 | 13G | Aclaris Therapeutics, Inc. ACRS |
BML Investment Partners, L.P. | 4,500,000 6.400% |
4,500,000![]() (New Position) |
Filing History |
2024-01-10 5:39 pm Purchase |
2024-01-10 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 70,468 4.800% |
1,065![]() (+1.53%) |
Filing History |
2023-11-24 11:33 am Purchase |
2023-11-13 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
BML Investment Partners, L.P. | 1,815,953 6.600% |
1,815,953![]() (New Position) |
Filing History |
2023-10-02 11:45 am Purchase |
2023-09-25 | 13G | Atea Pharmaceuticals, Inc. AVIR |
BML Investment Partners, L.P. | 4,183,645 5.000% |
4,183,645![]() (New Position) |
Filing History |
2023-09-15 12:00 pm Unchanged |
2023-09-15 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 4.780% |
0 (Unchanged) |
Filing History |
2023-07-24 3:23 pm Purchase |
2023-07-13 | 13G | AVROBIO, Inc. AVRO |
BML Investment Partners, L.P. | 330,450 9.000% |
330,450![]() (New Position) |
Filing History |
2023-07-17 11:07 am Purchase |
2023-07-06 | 13G | Quince Therapeutics, Inc. QNCX |
BML Investment Partners, L.P. | 1,841,301 5.070% |
1,841,301![]() (New Position) |
Filing History |
2023-06-26 4:00 pm Unchanged |
2023-06-26 | 13D | Astrotech Corporation ASTC |
BML Investment Partners, L.P. | 232,065 13.700% |
0 (Unchanged) |
Filing History |
2023-06-12 6:57 pm Sale |
2023-06-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 0 0.000% |
-6,590,000![]() (Position Closed) |
Filing History |
2023-04-27 2:19 pm Unchanged |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
0 (Unchanged) |
Filing History |
2023-04-27 10:55 am Purchase |
2023-04-17 | 13G | Talaris Therapeutics, Inc. TALS |
BML Investment Partners, L.P. | 218,919 5.200% |
218,919![]() (New Position) |
Filing History |
2023-03-29 11:17 am Purchase |
2023-03-24 | 13D | Forte Biosciences, Inc. FBRX |
BML Investment Partners, L.P. | 69,403 8.260% |
10,948![]() (+18.73%) |
Filing History |
2023-03-17 10:15 am Purchase |
2023-03-09 | 13G | Embark Technology, Inc. EMBK |
BML Investment Partners, L.P. | 994,355 5.200% |
994,355![]() (New Position) |
Filing History |
2023-02-08 5:29 pm Sale |
2023-02-08 | 13G | Astrotech Corporation ASTC |
BML Investment Partners, L.P. | 232,065 13.700% |
-5,247,257![]() (-95.76%) |
Filing History |
2023-02-08 5:24 pm Unchanged |
2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
BML Investment Partners, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
2023-02-08 5:23 pm Sale |
2023-02-08 | 13G | Terns Pharmaceuticals, Inc. TERN |
BML Investment Partners, L.P. | 0 0.000% |
-1,764,274![]() (Position Closed) |
Filing History |
2023-02-08 5:09 pm Unchanged |
2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS |
BML Investment Partners, L.P. | 4,867,984 7.800% |
0 (Unchanged) |
Filing History |
2023-02-08 5:06 pm Unchanged |
2023-02-08 | 13G | Graybug Vision, Inc. GRAY |
BML Investment Partners, L.P. | 88,282 5.700% |
0 (Unchanged) |
Filing History |
2023-02-08 4:55 pm Purchase |
2023-02-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 6,590,000 19.900% |
150,000![]() (+2.33%) |
Filing History |
2023-02-08 4:44 pm Purchase |
2023-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
BML Investment Partners, L.P. | 730,018 7.300% |
212,468![]() (+41.05%) |
Filing History |